Skip to content

The headache- and migraine-inducing effects of pitolisant in women with migraine without aura

Status
Not yet recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2026-525521-20-00
Enrollment
14
Registered
2026-03-26
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine without aura

Brief summary

The occurrence of migraine-like attacks in pitolisant- and placebo-treated women with migraine without aura

Detailed description

Headache intensity over time, expressed as the area under the curve (AUC), following pitolisant and placebo administration in women with migraine without aura, The occurrence of any headache, irrespective of migraine criteria, following pitolisant and placebo administration

Interventions

DRUGIBUPROFEN
DRUGSUMATRIPTAN

Sponsors

Syddansk Universitet (University of Southern Denmark)
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Design outcomes

Primary

MeasureTime frame
The occurrence of migraine-like attacks in pitolisant- and placebo-treated women with migraine without aura

Secondary

MeasureTime frame
Headache intensity over time, expressed as the area under the curve (AUC), following pitolisant and placebo administration in women with migraine without aura, The occurrence of any headache, irrespective of migraine criteria, following pitolisant and placebo administration

Outcome results

None listed

Source: EU CTIS · Data processed: Mar 27, 2026